Cargando…
A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma
Mycobacterial preparations have been used with limited success against cancer apart from superficial bladder cancer. Recently, a therapeutic vaccine derived from Mycobacterium vaccae has been given to patients with prostate cancer and melanoma indicating a possible beneficial effect on disease activ...
Autores principales: | O’Brien, M E R, Saini, A, Smith, I E, Webb, A, Gregory, K, Mendes, R, Ryan, C, Priest, K, Bromelow, K V, Palmer, R D, Tuckwell, N, Kennard, D A, Souberbielle, B E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374669/ https://www.ncbi.nlm.nih.gov/pubmed/10970684 http://dx.doi.org/10.1054/bjoc.2000.1401 |
Ejemplares similares
-
Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma
por: Mendes, R, et al.
Publicado: (2002) -
Vaccine: From vacca, a cow
por: Turley, Patrick K.
Publicado: (2021) -
The self-regulation for learning online (SRL-O) questionnaire
por: Broadbent, Jaclyn, et al.
Publicado: (2022) -
Cómo hacer una S.R.L.
por: Taleva Salvat, Orlando -
Mycobacterium vaccae Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials
por: de Carvalho, Carla C. C. R., et al.
Publicado: (2020)